Diversity in receptor signalling: cellular individuality and the search for selective drugs.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 1645767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent developments in the molecular pharmacology of receptor signalling are reviewed. Receptors and other signalling molecules belong to superfamilies characterized by variations on given themes. A remarkable degree of diversity is generated by unique combinations of molecular entities, and there are also interactions between parallel signal transduction pathways. Molecular biology techniques have revealed new targets for drug development, as well as new methods of drug testing. However, it is not yet clear whether molecular and biochemical specificity always correspond to clinical selectivity.
Medical subject headings
- Animals
- GTP-Binding Proteins
- GTP-Binding Proteins/metabolism
- GTP-Binding Proteins/physiology
- Humans
- Lymphocytes
- Lymphocytes/metabolism
- Receptors, Drug
- Receptors, Drug/chemistry
- Receptors, Drug/physiology
- Receptors, GABA-A
- Receptors, GABA-A/physiology
- Receptors, Nicotinic
- Receptors, Nicotinic/chemistry
- Receptors, Nicotinic/physiology
- Second Messenger Systems
- Second Messenger Systems/physiology
- Signal Transduction
- Signal Transduction/drug effects
- Signal Transduction/physiology